指南与共识慢性肾脏病肾移植肾小球疾病

KDIGO 2022 慢性肾脏病丙型肝炎预防、诊断、评估和治疗临床实践指南执行摘要

Executive Summary of the KDIGO 2022 Clinical Practice Guideline for the Prevention, Diagnosis, Evaluation, and Treatment of Hepatitis C in Chronic Kidney Disease.
指南 / 共识 · Kidney Int · 2022-01-01

KDIGO 工作组对2018年丙型肝炎病毒(HCV)指南进行综合审查并更新,本执行摘要重点介绍3章关键推荐:第2章慢性肾脏病患者HCV感染的治疗;第4章肾移植前后HCV感染患者的管理;第5章HCV感染相关肾脏疾病的诊断与管理。更新基于抗病毒治疗及HCV相关肾小球疾病治疗进展和HCV阳性肾移植使用增加。

要点

  • 更新重点为CKD患者HCV感染治疗、肾移植前后管理及HCV相关肾脏疾病诊治。
  • 2018版指南发布后抗病毒治疗和HCV相关肾小球疾病治疗进展促成此次修订。
  • HCV阳性肾移植使用增加是本次指南更新的重要背景之一。

核心结论

  • KDIGO工作组对2018年HCV指南进行综合审查并修订,本执行摘要突出3章更新推荐。

研究设计与样本

  • KDIGO工作组对2018年HCV指南进行综合审查并修订,形成更新版指南执行摘要。

主要发现

  • 自2018年KDIGO HCV指南发布后,抗病毒治疗和HCV相关肾小球疾病治疗进展及HCV阳性肾移植使用增加促成指南再审查。
  • 本执行摘要重点介绍第2章CKD患者HCV感染治疗、第4章肾移植前后HCV感染患者管理、第5章HCV感染相关肾脏疾病诊断与管理。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Infection with the hepatitis C virus (HCV) has adverse liver, kidney, and cardiovascular consequences in patients with chronic kidney disease (CKD), including those on dialysis therapy or with a kidney transplant. Since the publication of the Kidney Disease: Improving Global Outcomes (KDIGO) HCV Guideline in 2018, advances in HCV management, particularly in the field of antiviral therapy and treatment of HCV-associated glomerular diseases, coupled with increased usage of HCV-positive kidney grafts, have prompted a reexamination of the 2018 guideline. As a result, the Work Group performed a comprehensive review and revised the 2018 guidance. This Executive Summary highlights key aspects of the updated guideline recommendations for 3 chapters: Chapter 2: Treatment of HCV infection in patients with CKD; Chapter 4: Management of HCV-infected patients before and after kidney transplantation; and Chapter 5: Diagnosis and management of kidney diseases associated with HCV infection.

来源:Kidney Int,查看原文。版权归原作者所有。

引用

  1. Martin P, Awan AA, Berenguer MC, et al. Executive Summary of the KDIGO 2022 Clinical Practice Guideline for the Prevention, Diagnosis, Evaluation, and Treatment of Hepatitis C in Chronic Kidney Disease. Kidney Int. 2022. PMID: 36411019. doi:10.1016/j.kint.2022.07.012

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。